Levels of symptom burden during chemotherapy for advanced lung cancer: Differences between public hospitals and a tertiary cancer center

Journal of Clinical Oncology

Volumn 29, Issue 21, 2011, Pages 2859-2865

  Cleeland, Charles S ^a   Mendoza, Tito R ^a   Wang, Xin Shelley ^a   Woodruff, Jeanie F ^a   Palos, Guadalupe R ^a   Richman, Stephen P ^c   Nazario, Arlene ^a   Lynch, Garrett R ^b   Liao, Kai Ping ^a   Mobley, Gary M ^a   Lu, Charles ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DOCETAXEL; ERLOTINIB; PACLITAXEL; PLATINUM;

ADULT; ADVANCED CANCER; CANCER CENTER; CANCER CHEMOTHERAPY; CONFERENCE PAPER; DISEASE SEVERITY; EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS; EDUCATIONAL STATUS; ETHNICITY; FEMALE; HEALTH CARE DISPARITY; HUMAN; LUNG NON SMALL CELL CANCER; M D ANDERSON SYMPTOM INVENTORY; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PAIN; PATIENT MONITORING; PRIORITY JOURNAL; PUBLIC HOSPITAL; RACE DIFFERENCE; RISK FACTOR; SCORING SYSTEM; SYMPTOM; TERTIARY CANCER CENTER; TREATMENT OUTCOME;

ACADEMIC MEDICAL CENTERS; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; COST OF ILLNESS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HOSPITALS, PUBLIC; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; LUNG NEOPLASMS; MALE; MEDICALLY UNDERSERVED AREA; MIDDLE AGED; ODDS RATIO; PROPENSITY SCORE; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 79960736597     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.33.4425     Document Type: Conference Paper

References (25)

1. Cleeland CS: Symptom burden: Multiple symptoms and their impact as patient-reported outcomes. J Natl Cancer Inst Monographs 37:16-21, 2007
2. Ocaña A, Amir E, Vera F, et al: Addition of bevacizumab to chemotherapy for treatment of solid tumors: Similar results but different conclusions. J Clin Oncol 29:254-256, 2011
3. Bernabei R, Gambassi G, Lapane K, et al: Management of pain in elderly patients with cancer. SAGE Study Group: Systematic Assessment of Geriatric Drug Use via Epidemiology. JAMA 279:1877-1882, 1998
4. Cleeland CS, Gonin R, Hatfield AK, et al: Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 330:592-596, 1994 (Pubitemid 24065792)
5. Cleeland CS, Portenoy RK, Rue M, et al: Does an oral analgesic protocol improve pain control for patients with cancer? An intergroup study coordinated by the Eastern Cooperative Oncology Group. Ann Oncol 16:972-980, 2005 (Pubitemid 40903925)
6. Sloane D: Cancer epidemiology in the United States: Racial, social, and economic factors. Methods Mol Biol 471:65-83, 2009
7. Patel UA, Lynn-Macrae A, Rosen F, et al: Advanced stage of head and neck cancer at a tertiary-care county hospital. Laryngoscope 116: 1473-1477, 2006 (Pubitemid 44181467)
8. U.S. Department of Health and Human Services, Health Resources and Services Administration: Shortage designation: Medically underserved areas & populations. http://bhpr.hrsa.gov/shortage/muaguide.htm
9. Cleeland CS, Mendoza TR, Wang XS, et al: Assessing symptom distress in cancer patients: The M. D. Anderson Symptom Inventory. Cancer 89:1634-1646, 2000
10. Mendoza TR, Wang XS, Lu C, et al: Measuring the symptom burden of lung cancer: The validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory. Oncologist 16:217-227, 2011
11. Wang XS, Cleeland CS, Mendoza TR, et al: Impact of cultural and linguistic factors on symptom reporting by patients with cancer. J Natl Cancer Inst 102:732-738, 2010
12. Oken MM, Creech RH, Tormey DC, et al: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649-655, 1982 (Pubitemid 13149996)
13. Charlson M, Szatrowski TP, Peterson J, et al: Validation of a combined comorbidity index. J Clin Epidemiol 47:1245-1251, 1994 (Pubitemid 24361532)
14. Wang XS, Shi Q, Lu C, et al: Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancer. Cancer 116:137-145, 2010
15. Leslie RS, Ghomrawi H: The use of propensity scores and instrumental variable methods to adjust for treatment selection bias. Presented at the SAS Global Forum 2008, San Antonio TX, March 16, 2008
16. Jones BL, Nagin DS, Roeder K, et al: A SAS procedure based on mixture models for estimating developmental trajectories. Sociological Methods & Research 29:374-393, 2001
17. Hosmer DW, Lemeshow S: Applied logistic regression (ed 2). New York, NY, Wiley, 2000
18. Fitzmaurice GM, Laird NM, Ware JH, et al: Applied longitudinal analysis. Hoboken, NJ, Wiley-Interscience, 2004
19. Serlin RC, Mendoza TR, Nakamura Y, et al: When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 61:277-284, 1995
20. Holmes L Jr, Chan W, Jiang Z, et al: Impact of androgen deprivation therapy on racial/ethnic disparities in the survival of older men treated for locoregional prostate cancer. Cancer Control 16:176-185, 2009
21. Terplan M, Smith EJ, Temkin SM, et al: Race in ovarian cancer treatment and survival: A systematic review with meta-analysis. Cancer Causes Control 20:1139-1150, 2009
22. Morrison RS, Wallenstein S, Natale DK, et al: "We don't carry that" - failure of pharmacies in predominantly nonwhite neighborhoods to stock opioid analgesics. N Engl J Med 342:1023-1026, 2000 (Pubitemid 30180650)
23. Darby K, Davis C, Likes W, et al: Exploring the financial impact of breast cancer for African American medically underserved women: A qualitative study. J Health Care Poor Underserved 20:721-728, 2009
24. Ok H, Marks R, Allegrante JP, et al: Perceptions of health care provider communication activity among American cancer survivors and adults without cancer histories: An analysis of the 2003 Health Information Trends Survey (HINTS) Data. J Health Commun 13:637-653, 2008
25. Patrick DL, Ferketich SL, Frame PS, et al: National Institutes of Health State-of-the-Science Conference statement: Symptom management in cancer: Pain, depression, and fatigue, July 15-17, 2002. J Natl Cancer Inst 95:1110-1117, 2003